The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2016

Filed:

Sep. 30, 2014
Applicant:

The Boeing Company, Huntington Beach, CA (US);

Inventors:

Mark Jonathan Handel, Seattle, WA (US);

Douglas Alan Stuart, St. Charles, MO (US);

Hugh L Taylor, Mukilteo, WA (US);

Steven A. Dorris, Saint Peters, MO (US);

Brett Michael Wilson, Seattle, WA (US);

Assignee:

The Boeing Company, Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 11/00 (2006.01); G06F 12/14 (2006.01); G06F 12/16 (2006.01); G08B 23/00 (2006.01); H04L 29/06 (2006.01); H04L 29/08 (2006.01); G06F 21/55 (2013.01);
U.S. Cl.
CPC ...
H04L 63/1441 (2013.01); G06F 21/55 (2013.01); H04L 63/1408 (2013.01); H04L 67/10 (2013.01); H04L 63/14 (2013.01); H04L 63/145 (2013.01); H04L 63/1416 (2013.01); H04L 63/1425 (2013.01); H04L 67/12 (2013.01);
Abstract

Artificial Immune Systems (AIS) including the Dendritic Cell Algorithm (DCA) are an emerging method to detect malware in computer systems. The DCA implementation may use an inflammation signal to communicate information among the processes of device or a network or among nodes of a network, where the inflammatory signal indicates a likelihood that a process or a node has been attacked by malicious software. The DCA implementation may dynamically change the malware sensitivity and responsiveness based on the inflammation signals without requiring user intervention. The inflammatory signal includes one or more inflammatory tuples, which may include multiple components such as a strength, a PrimeIndicator, and an optional third element, p. The strength component may be an indication of the magnitude of an attack and provide a degree of certainty of the attack. The PrimeIndicator may be an identifier of the indicator type that is the source of the inflammation tuple.


Find Patent Forward Citations

Loading…